Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer’s Disease

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2015-07-09

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.3233/JAD-150128PMID 26402771PMCID PMC4634634
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Considering the base rates of low performance in cognitively healthy older adults improves the accuracy to identify neurocognitive impairment with the Consortium to Establish a Registry for Alzheimer’s Disease-Neuropsychological Assessment Battery (CERAD-NAB)

  2015cited by this paper
• Susceptibility of the conventional criteria for mild cognitive impairment to false‐positive diagnostic errors

  2015cited by this paper
• Secondary prevention trials in Alzheimer disease: the challenge of identifying a meaningful end point.

  2014cited by this paper
• This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon. Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition

  2014cited by this paper
• The amyloid hypothesis, time to move on: Amyloid is the downstream result, not cause, of Alzheimer's disease

  2014cited by this paper
• Biological heterogeneity in ADNI amnestic mild cognitive impairment

  2014cited by this paper
• P1‐341: FREE RECALL CAN INDICATE ALZHEIMER'S DISEASE AS LONG AS THERE IS NO CEILING EFFECT

  2014cited by this paper
• Neuropsychological Criteria for Mild Cognitive Impairment Improves Diagnostic Precision, Biomarker Associations, and Progression Rates

  2014cited by this paper
• Integration and relative value of biomarkers for prediction of MCI to AD progression: Spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers

  2013cited by this paper
• Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study.

  2013cited by this paper
• Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity

  2013cited by this paper
• TDP-43 pathology, cognitive decline, and dementia in old age.

  2013cited by this paper
• Brain injury biomarkers are not dependent on β‐amyloid in normal elderly

  2013cited by this paper
• Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.

  2013cited by this paper
• Alzheimer's Disease Neurodegenerative Biomarkers Are Associated with Decreased Cognitive Function but Not β-Amyloid in Cognitively Normal Older Individuals

  2013influential reference
• Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid

  2013cited by this paper
• Are Empirically-Derived Subtypes of Mild Cognitive Impairment Consistent with Conventional Subtypes?

  2013cited by this paper
• MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy study

  2013cited by this paper
• Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease

  2012cited by this paper
• An operational approach to National Institute on Aging–Alzheimer's Association criteria for preclinical Alzheimer disease

  2012cited by this paper
• A computational neurodegenerative disease progression score: Method and results with the Alzheimer's disease neuroimaging initiative cohort

  2012cited by this paper
• Neuropsychological measures predict decline to Alzheimer's dementia from mild cognitive impairment.

  2012cited by this paper
• Reversion from mild cognitive impairment to normal or near-normal cognition

  2012cited by this paper
• A web-based normative calculator for the uniform data set (UDS) neuropsychological test battery

  2011cited by this paper
• Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years

  2011cited by this paper
• Predicting MCI outcome with clinically available MRI and CSF biomarkers

  2011cited by this paper
• The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders

  2011cited by this paper
• Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.

  2011cited by this paper
• Outcomes of mild cognitive impairment by definition: a population study.

  2011cited by this paper
• Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.

  2011cited by this paper
• The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• APOE4 Allele Disrupts Resting State fMRI Connectivity in the Absence of Amyloid Plaques or Decreased CSF Aβ42

  2010cited by this paper
• Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

  2010influential reference
• Alzheimer's Disease Neuroimaging Initiative (ADNI)

  2010cited by this paper
• Heterogeneity in mild cognitive impairment: Differences in neuropsychological profile and associated white matter lesion pathology

  2009cited by this paper
• Quantification of five neuropsychological approaches to defining mild cognitive impairment.

  2009influential reference
• The neuropathology of probable Alzheimer disease and mild cognitive impairment

  2009cited by this paper
• The heterogeneity of mild cognitive impairment: A neuropsychological analysis

  2009cited by this paper
• The Alzheimer's Disease Centers' Uniform Data Set (UDS): The Neuropsychologic Test Battery

  2009cited by this paper
• Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

  2009cited by this paper
• Frequency and bases of abnormal performance by healthy adults on neuropsychological testing

  2008cited by this paper
• Substantial risk of “Accidental MCI” in healthy older adults: Base rates of low memory scores in neuropsychological assessment

  2007cited by this paper
• Base rates of "impaired" neuropsychological test performance among healthy older adults.

  1998cited by this paper
• Mayo's older americans normative studies: Updated AVLT norms for ages 56 to 97

  1992cited by this paper

• Depressive symptoms mediate the relationship between cognitive reserve and cognitive performance in middle-aged and older Chinese adults: evidence from population-based and clinical PET cohorts including cognitively normal and cognitively impaired participants

  2026cites this paper
• Mood Symptoms are Associated With Cognitive Status, Brain Amyloid-Beta Deposition, and Plasma Biomarkers

  2025cites this paper
• Klinische und neuropsychologisch-operationalisierte Kriterien zur Früherkennung eines Mild Cognitive Impairment: Eine Übersicht und kritische Einordnung

  2025cites this paper
• Beyond Alzheimer's disease-translating biomarker insights across CNS diseases.

  2025cites this paper
• Amnestic Transitional Cognitive Decline in Aging and Preclinical Alzheimer's Disease

  2025cites this paper
• Longitudinal Associations of Multimodal Core 1 Alzheimer Disease Biomarkers With Cognition in Aging and Preclinical Alzheimer Disease

  2025cites this paper
• Pain in Older Adults with Cognitive Impairment: A Review on the Relationship Between Chronic Pain and Subjective Cognitive Decline.

  2025cites this paper
• Sarcopenia index is associated with Alzheimer’s disease, mild cognitive impairment and their mortality in Chinese adults aged 65 and older

  2025cites this paper
• Reliability and validity analysis of the Chinese version of the Quick Dementia Rating System (QDRS)

  2025cites this paper
• Early identification of cognitive impairment in older adults from Advanced Activities of Daily Living (AADL): A scoping review.

  2025cites this paper
• Character-level linguistic biomarkers for precision assessment of cognitive decline: a symbolic recurrence approach

  2025cites this paper
• Precision neurocognition: An emerging diagnostic paradigm leveraging digital cognitive assessment technology

  2025cites this paper
• Metagenomic analysis characterizes stage-specific gut microbiota in Alzheimer’s disease

  2025cites this paper
• Cognitive Frailty: A Comprehensive Clinical Paradigm Beyond Cognitive Decline.

  2025cites this paper
• Associations between the logical memory test story recall metrics and plasma biomarkers for Alzheimer’s disease in individuals free of dementia

  2025cites this paper
• Association of objective subtle cognitive difficulties with amyloid-β and tau deposition compared to subjective cognitive decline

  2025cites this paper
• Longitudinal Analysis of Objective and Self-Reported Cognitive Functions in Individuals with Subjective Cognitive Decline

  2025cites this paper
• Alteration of functional connectivity network in population of objectively-defined subtle cognitive decline

  2024cites this paper
• Tau PET positivity predicts clinically relevant cognitive decline driven by Alzheimer’s disease compared to comorbid cases; proof of concept in the ADNI study

  2024cites this paper
• Associations of Post-Traumatic Stress Disorder and Objective Subtle Cognitive Difficulties in Cognitively Unimpaired Older Veterans.

  2024cites this paper
• Association between elevated systemic inflammatory markers and the risk of cognitive decline progression: a longitudinal study

  2024cites this paper
• Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals

  2024cites this paper
• Clusters of cognitive performance predict long‐term cognitive impairment in elderly patients with subjective memory complaints and healthy controls

  2024cites this paper
• Reserve, resilience and maintenance of episodic memory and other cognitive functions in aging.

  2024cites this paper
• Predictive models for Alzheimer's disease diagnosis and MCI identification: The use of cognitive scores and artificial intelligence algorithms

  2024cites this paper
• Association between elevated blood-brain barrier permeability and the risk of progressive cognitive decline: A longitudinal study.

  2024cites this paper
• Whole Transcriptome Sequencing of Peripheral Blood Identifies the Alzheimer's Disease-Related circRNA-miRNA-lncRNA Pathway.

  2024cites this paper
• Cognitive resilience in Alzheimer’s disease: from large-scale brain networks to synapses

  2024cites this paper
• Cognitive criteria in HIV: greater consensus is needed

  2024cites this paper
• The Effect of Gender and APOE ɛ4 Status on Brain Amyloid-β Deposition in Different Age Groups of Mild Cognitively Impaired Individuals: A PET-CT Study

  2023cites this paper
• Neuropsychiatric symptoms in Alzheimer's continuum and their association with plasma biomarkers.

  2023cites this paper
• Exploring Spoken Discourse and Its Neural Correlates in Women With Alzheimer's Disease With Low Levels of Education and Socioeconomic Status.

  2023cites this paper
• Instrumental activities of daily living and mild cognitive impairment

  2023cites this paper
• Altered cortical and subcortical morphometric features and asymmetries in the subjective cognitive decline and mild cognitive impairment

  2023cites this paper
• Subjective cognitive decline and cerebral-cognitive reserve in late age

  2023cites this paper
• Using digital assessment technology to detect neuropsychological problems in primary care settings

  2023cites this paper
• Positive rate and quantification of amyloid pathology with [18F]florbetapir in the urban Chinese population

  2023cites this paper
• Verifying and refining early statuses in Alzheimer's disease progression: a possibility from deep feature comparison.

  2023cites this paper
• Shanghai Cognitive Screening: A Mobile Cognitive Assessment Tool Using Voice Recognition to Detect Mild Cognitive Impairment and Dementia in the Community

  2023cites this paper
• Grey matter volume and CSF biomarkers predict neuropsychological subtypes of MCI.

  2023cites this paper
• Original research: longitudinal evaluation of cognitively demanding daily function using performance-based functional assessment highlights heterogeneous trajectories in cognitive and functional abilities in people with Parkinson’s disease

  2023cites this paper
• Application and validation of an algorithmic classification of early impairment in cognitive performance

  2023cites this paper
• Correlating continuously captured home-based digital biomarkers of daily function with postmortem neurodegenerative neuropathology

  2023cites this paper
• Longitudinal association between ß-amyloid accumulation and cognitive decline in cognitively healthy older adults: A systematic review

  2023cites this paper
• Prevalence and risk factors for subjective cognitive decline and the correlation with objective cognition among community‐dwelling older adults in China: Results from the Hubei memory and aging cohort study

  2023cites this paper
• Correlation between ankle‐brachial index and subtle cognitive decline

  2023influential citation
• Association of Stages of Objective Memory Impairment With Incident Symptomatic Cognitive Impairment in Cognitively Normal Individuals

  2023cites this paper
• Association between Neuropsychological Performance and CSF Profile in Subjective Cognitive Decline: Towards the Diagnosis of Preclinical AD

  2023cites this paper
• Developing Early Markers of Cognitive Decline and Dementia Derived From Survey Response Behaviors: Protocol for Analyses of Preexisting Large-scale Longitudinal Data

  2023cites this paper
• The ambivalence toward neuropsychology in dementia research, diagnosis, and drug development: Myths and misconceptions

  2023cites this paper
• AMES: An Automated Self-Administered Scale to Detect Incipient Cognitive Decline in Primary Care Settings

  2023influential citation
• Brain Functional Alterations and Association with Cognition in People with Preclinical Subjective Cognitive Decline and Objective Subtle Cognitive Difficulties.

  2023cites this paper
• Diagnostic Utility of Hippocampal Volumetric Data in a Memory Disorder Clinic Setting

  2022cites this paper
• DNA methylation-based measures of biological aging and cognitive decline over 16-years: preliminary longitudinal findings in midlife

  2022cites this paper
• Altered functional connectivity pattern of hippocampal subfields in individuals with objectively‐defined subtle cognitive decline and its association with cognition and cerebrospinal fluid biomarkers

  2022cites this paper
• Association between age‐related hearing loss with tinnitus and cognitive performance in older community‐dwelling Chinese adults

  2022cites this paper
• Capturing Cognitive Aging in Vivo: Application of a Neuropsychological Framework for Emerging Digital Tools

  2022cites this paper
• The frequency of self-reported memory failures is influenced by everyday context across the lifespan: Implications for neuropsychology research and clinical practice

  2022cites this paper
• Tau levels are higher in objective subtle cognitive decline but not subjective memory complaint

  2022cites this paper
• Dissociating Statistically Determined Normal Cognitive Abilities and Mild Cognitive Impairment Subtypes with DCTclock

  2022influential citation
• Intestinal Flora Balance Therapy Based on Probiotic Support Improves Cognitive Function and Symptoms in Patients with Alzheimer's Disease: A Systematic Review and Meta-analysis

  2022cites this paper
• Neuropsychological Decline Stratifies Dementia Risk in Cognitively Unimpaired and Impaired Older Adults

  2022cites this paper
• Longitudinal Intraindividual Cognitive Variability Is Associated With Reduction in Regional Cerebral Blood Flow Among Alzheimer’s Disease Biomarker-Positive Older Adults

  2022cites this paper
• APOE ε4 Allele Distribution and Association With Scores of Subjective Cognitive Decline Questionnaire 9 in a Large Chinese Memory Clinic Cohort

  2022cites this paper
• Using the Montreal cognitive assessment to identify individuals with subtle cognitive decline.

  2022cites this paper
• Brain Photobiomodulation Improves Sleep Quality in Subjective Cognitive Decline: A Randomized, Sham-Controlled Study

  2022cites this paper
• Practice Effects in Mild Cognitive Impairment Increase Reversion Rates and Delay Detection of New Impairments

  2022cites this paper
• The Boston Process Approach and Digital Neuropsychological Assessment: Past Research and Future Directions

  2022cites this paper
• Categorical predictive and disease progression modeling in the early stage of Alzheimer's disease.

  2022cites this paper
• Clinical and Objective Cognitive Measures for the Diagnosis of Cognitive Frailty Subtypes: A Comparative Study

  2021cites this paper
• Autobiographical Memory Fluency Reductions in Cognitively Unimpaired Middle-Aged and Older Adults at Increased Risk for Alzheimer’s Disease Dementia

  2021cites this paper
• A Novel Computerized Cognitive Stress Test to Detect Mild Cognitive Impairment

  2021cites this paper
• Empirically defining the preclinical stages of the Alzheimer's continuum in the Alzheimer's Disease Neuroimaging Initiative

  2021cites this paper
• Latent Profile Analysis of Cognition in a Non-Demented Diverse Cohort: A Focus on Modifiable Cardiovascular and Lifestyle Factors

  2021cites this paper
• Validity Evidence for the Research Category, “Cognitively Unimpaired – Declining,” as a Risk Marker for Mild Cognitive Impairment and Alzheimer’s Disease

  2021cites this paper
• The functional activities questionnaire

  2021cites this paper
• Latent Cognitive Class at Enrollment Predicts Future Cognitive Trajectories of Decline in a Community Sample of Older Adults

  2021cites this paper
• Association between handgrip strength and cognition in a Chinese population with Alzheimer’s disease and mild cognitive impairment

  2021cites this paper
• A deep learning approach for monitoring parietal-dominant Alzheimer’s disease in World Trade Center responders at midlife

  2021cites this paper
• Is comprehensiveness critical? Comparing short and long format cognitive assessments in preclinical Alzheimer disease

  2021cites this paper
• Enhancing the Sensitivity of Memory Tests: Reference Data for the Free and Cued Selective Reminding Test and the Logical Memory Task from Cognitively Healthy Subjects with Normal Alzheimer’s Disease Cerebrospinal Fluid Biomarker Levels

  2021cites this paper
• Dementia

  2021cites this paper
• Engineering extracellular vesicles for Alzheimer's disease: An emerging cell-free approach for earlier diagnosis and treatment.

  2021cites this paper
• Subjective cognitive impairment —more questions than answers

  2021cites this paper
• Fusion analysis of gray matter and white matter in subjective cognitive decline and mild cognitive impairment by multimodal CCA-joint ICA

  2021cites this paper
• Subtle mistakes in self‐report surveys predict future transition to dementia

  2021cites this paper
• Increased regional white matter hyperintensity volume in objectively‐defined subtle cognitive decline and mild cognitive impairment

  2021cites this paper
• Development and Preliminary Validation of Standardized Regression-Based Change Scores as Measures of Transitional Cognitive Decline.

  2020cites this paper
• Cross-sectional associations of amyloid burden with semantic cognition in older adults without dementia: A systematic review and meta-analysis

  2020cites this paper
• Recurrent and concurrent patterns of regional BOLD dynamics and functional connectivity dynamics in cognitive decline

  2020cites this paper
• An Initial Empirical Operationalization of the Earliest Stages of the Alzheimer's Continuum.

  2020cites this paper
• Spatial Mental Transformation Skills Discriminate Fitness to Drive in Young and Old Adults

  2020cites this paper
• Reynolds Intellectual Screening Instrument 1st versus 2nd Edition in a Memory Disorder Sample.

  2020cites this paper
• Clinical Assessment and Intervention With Persons Living With Dementia

  2020cites this paper
• A Conceptual Framework for Research on Cognitive Impairment with no Dementia in Memory Clinic.

  2020cites this paper
• Beyond PD-MCI: objectively defined subtle cognitive decline predicts future cognitive and functional changes

  2020cites this paper
• Demographically Corrected Normative Z Scores on the Neuropsychological Test Battery in Cognitively Normal Older Chinese Adults

  2020cites this paper
• Cognitive impairment and decline in cognitively normal older adults with high amyloid-b: A meta-analysis

  2020cites this paper
• Regional hyperperfusion in older adults with objectively-defined subtle cognitive decline

  2020cites this paper
• Association of baseline semantic fluency and progression to mild cognitive impairment in middle-aged men

  2020cites this paper